- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Sensitizing EGFR Mutations
Total 2622 results
-
BayerRecruitingAdvanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationHong Kong, United States, Taiwan, Spain, Belgium, China, Japan, France, Korea, Republic of, Singapore, Poland, Israel, Italy, Netherlands, Portugal, Brazil
-
Anthony MaglioccoRecruiting
-
National University Hospital, SingaporeBoehringer IngelheimRecruitingNon-Small Cell Lung Cancer | Epidermal Growth Factor Receptor MutationSingapore
-
Shanghai Chest HospitalAllist Pharmaceuticals, Inc.RecruitingNon-Small-Cell Lung CancerChina
-
Shanghai Chest HospitalJiangsu Hansoh Pharmaceutical Co., Ltd.Not yet recruitingLung Cancer | EGFR Gene Mutation
-
Beijing Dongfang Biotech Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesNot yet recruiting
-
Shanghai Chest HospitalNot yet recruiting
-
Yonsei UniversityRecruitingNon Small Cell Lung CancerKorea, Republic of
-
Fondazione Ricerca TraslazionaleRecruiting
-
Tianjin Medical University Cancer Institute and...RecruitingNon Small Cell Lung CancerChina
-
National Guard Health AffairsRecruiting
-
Li Zhang, MDNot yet recruiting
-
Shanghai Chest HospitalRecruitingNon-small Cell Lung Cancer Metastatic | EGF-R Positive Non-Small Cell Lung CancerChina
-
PfizerRecruitingEGFR Mutation-positive Inoperable or Reccrent NSCLCJapan
-
Centre Francois BaclesseGFPCRecruitingALK Gene Rearrangement Positive | NSCLC Stage IV | NSCLC Stage IIIB | EGFR Gene Mutation | ROS1 Gene MutationFrance
-
Tianjin Medical University Cancer Institute and...RecruitingNon-squamous Non-small Cell Lung CancerChina
-
AstraZenecaHutchison MediPharmaRecruitingCarcinomaDenmark, Spain, United States, Taiwan, Vietnam, Canada, Korea, Republic of, Brazil, India, Japan, Italy, Puerto Rico, France, Chile
-
Qilu Pharmaceutical Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Chinese... and other collaboratorsNot yet recruiting
-
National Cancer Institute (NCI)RecruitingAdvanced Lung Non-Small Cell Carcinoma | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7United States
-
Apollomics Inc.RecruitingGastric Cancer | Pancreatic Cancer | NSCLC | Lung Cancer | Brain Tumor | Glioblastoma Multiforme | Advanced Cancer | Colon Cancer | Solid Tumors | Thyroid Cancer | Renal Cancer | Gastroesophageal Junction Adenocarcinoma | EGFR Gene Mutation | MET Amplification | HGF | MET Alteration | MET Fusion | Exon 14 SkippingUnited States, Spain, France, United Kingdom, Taiwan, Australia, Finland, Italy, Singapore, Hungary, Canada, Puerto Rico, Russian Federation
-
Sun Yat-sen UniversityRecruitingEGFR Tyrosine Kinase Inhibitors Plus VEGFR InhibitorsChina
-
AstraZenecaParexelActive, not recruitingLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung CancerBelgium, United States, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Italy, Korea, Republic of, Brazil, Japan, Turkey, China, Malaysia, Germany, Spain, Australia, Hungary, Portugal, Switzerland, Israel, Philippines, Russian... and more
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingNon Small Cell Lung Cancer | Nonsquamous Nonsmall Cell Neoplasm of Lung | Non Small Cell Lung Cancer Metastatic | Sensitizing EGFR Gene MutationUnited States, Korea, Republic of, Singapore, Taiwan
-
AstraZenecaParexelActive, not recruitingNon-small Cell Lung CancerItaly, Spain, United States, China, Germany, Israel
-
Institut du Cancer de Montpellier - Val d'AurelleActive, not recruiting
-
TakedaActive, not recruitingAdvanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)United States, Spain, France, Korea, Republic of, Hong Kong, Australia, Taiwan, United Kingdom, Canada, Turkey, Italy, China, Germany, Japan, Austria, Belgium, Greece, Israel, Netherlands, Portugal, Russian Federation, Singapore, Sw... and more
-
Shanghai JMT-Bio Inc.Active, not recruitingLocal Advanced or Metastatic NSCLC | Harboring EGFR Common MutationChina
-
Zhejiang Cancer HospitalJiangsu Hansoh Pharmaceutical Co., Ltd.Active, not recruiting
-
Yuhan CorporationActive, not recruitingNon-Small Cell Lung CancerHungary, Korea, Republic of, Australia, Taiwan, Serbia, Singapore, Thailand, Philippines, Turkey, Malaysia, Russian Federation, Greece, Ukraine
-
AstraZenecaActive, not recruitingNon Small Cell Lung CancerFrance
-
PfizerCompletedMetastatic Non Small Cell Lung CancerIndia
-
Dana-Farber Cancer InstituteAddario Lung Cancer Medical InstituteActive, not recruiting
-
Spectrum Pharmaceuticals, IncTerminatedBreast Cancer | Colorectal Cancer | Solid Tumor | Glioblastome MultiformeUnited States
-
Puma Biotechnology, Inc.TerminatedSolid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsFrance, United States, Spain, Belgium, United Kingdom, Serbia, Australia, Israel, Canada, Denmark, Ireland, Italy, Korea, Republic of
-
University of CologneCompletedBronchial NeoplasmsSpain, Germany
-
Spectrum Pharmaceuticals, IncSuspended
-
Novartis PharmaceuticalsTerminatedCarcinoma, Non-Small-Cell LungBelgium, Germany, United States, Canada, France, Italy, Japan, Korea, Republic of, Spain
-
University of VirginiaActive, not recruitingReal-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies (Lung001)Lung Cancer | ALK Gene Mutation | MET Gene Mutation | KRAS Mutation-Related Tumors | RET Gene Mutation | EGFR Gene Mutation | EGFR | ROS1 Gene Mutation | BRAFUnited States
-
Blueprint Medicines CorporationActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Metastatic Lung Cancer | Antineoplastic Agents | Brain Metastases | Lung Neoplasm Malignant | EGFR... and other conditionsUnited States, Canada, Korea, Republic of, Japan, Taiwan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Comprehensive Cancer NetworkActive, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
AstraZenecaCompletedNon Small Cell Lung CancerItaly, United States, Canada, Korea, Republic of, Japan, Taiwan, Hong Kong, Spain
-
Sheba Medical CenterAstraZenecaSuspendedCarcinoma, Non-Small-Cell Lung | Genes, erbB-1Israel
-
PfizerCompletedNon-small Cell Lung Cancer With EGFR-Activating MutationsItaly, Poland, China, Hong Kong, Spain, Korea, Republic of, Japan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Pharmacyclics LLC.Completed
-
AstraZenecaParexelCompletedEGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerSpain, United States, Italy, Korea, Republic of, Malaysia
-
Duke UniversityCompletedA Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR MutationsNon Small Cell Lung CancerUnited States
-
Juntendo UniversityMerck Sharp & Dohme LLCActive, not recruitingNon-squamous Non-small-cell Lung Cancer | EGFR Activating MutationJapan
-
Zhejiang Cancer HospitalCompleted
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore